EUVIMEDEUVIMED entdecken
Crossref

Combining artificial intelligence analysis with expert mammogram reading: Determining the optimal AI positivity cut-off point for the French population-based breast cancer screening program

Akoï Koïvogui, Gaëlle Abihsera, Samira Saifi, Michel Deghaye, Dominique Lamarque, Pascal Cherel, Guillaume Herpe, Nicolas Sellier

Cancer Epidemiology · 2026-08 · 103 · 103136

DOI: 10.1016/j.canep.2026.103136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Epidemiology, 2026-08. Verfasst von Akoï Koïvogui und 7 weiteren Autor:innen. Beteiligte Einrichtung: CRCDC-IDF, Pôle Data Etude Recherche et Evaluation, 28 rue Desaix, Paris 75015, France. Electronic address: aakoivogui@live.fr. Hauptthemen laut MEDLINE: Breast Neoplasms, Artificial Intelligence, Mammography, Early Detection of Cancer. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Artificial intelligence (AI) is increasingly explored as a complement to radiologists in population-based breast cancer screening, yet optimal strategies for its integration remain unclear. The French program relies on systematic double reading, a model challenged by rising workload and radiologist shortages. This study evaluates the performance of an AI algorithm and examines its potential role within the existing workflow. METHODS: A retrospective cohort study included 13,186 women aged 50-74 years who underwent screening mammography in Ile-de-France between 2018 and 2019. Mammograms classified as BI-RADS 1-2 at first reading were reviewed by a second radiologist and subsequently reinterpreted in 2023 using the Transpara© AI algorithm, which assigns a 0-100 risk score. ROC curve analysis identified an optimal positivity threshold (cut-off-P), and diagnostic performance metrics were calculated. Organizational scenarios considering AI placement upstream or downstream of the second reading were explored. RESULTS: The optimal cut-off-P was 36.2, yielding an AUC of 0.78. At this threshold, AI would have detected 18 of 22 cancers-including most interval-cancers- and reduced the absolute risk of interval-cancer after a negative screen by nine points. Applied upstream of the second reading, AI could have excluded approximately 60% of mammograms classified as benign at first reading, potentially reducing second-reader workload by two thirds, but at the cost of 4 missed cancers and 4807 false-positive classifications. However, false positives remained frequent, and a few cancers detected at second reading received low AI scores. CONCLUSION: AI shows substantial potential to streamline breast cancer screening by safely triaging negative examinations before second reading. Nonetheless, limitations related to false-positives and missed cancers support a complementary-rather than substitutive- role for AI, ideally positioned between first and second readings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsArtificial IntelligenceMammographyEarly Detection of CancerHumansFemaleMiddle AgedFranceRetrospective StudiesAgedMass Screening

Stichwörter der Autor:innen

Artificial intelligenceBreast cancerOptimal cut-off pointPopulation-based screening programScreening mammography

Autor:innen und Institutionen

  • CRCDC-IDF, Pôle Data Etude Recherche et Evaluation, 28 rue Desaix, Paris 75015, France. Electronic address: aakoivogui@live.fr.
  • CRCDC-IDF, Site du Val-de-Marne, Le banc de Sable, 7, Quai Gabriel Péri, Joinville-le-Pont 94340, France.
  • CRCDC-IDF, 28 rue Desaix, Paris 75015, France.
  • CRCDC-IDF, 28 rue Desaix, Paris 75015, France; Université Paris Saclay/Université de Versailles-Saint-Quentin-en-Yvelines (UVSQ) Département de Gastroentérologie, Versailles 78000, France; Assistance Publique des Hôpita…
  • Université de Poitiers, Laboratoire de Mathématiques et Applications, DACTIM MIS Lab, I3M, CNRS UMR, Poitiers 86000, France; Incepto Medical, Paris 75008, France.
  • CRCDC-IDF, 28 rue Desaix, Paris 75015, France; Université Sorbonne Paris Nord, Département de Radiologie, Villetaneuse 93430, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Jean-Verdier, Service Radiolog…

Zitieren

APA

Koïvogui, A., Abihsera, G., Saifi, S., Deghaye, M., Lamarque, D., Cherel, P., Herpe, G., & Sellier, N. (2026). Combining artificial intelligence analysis with expert mammogram reading: Determining the optimal AI positivity cut-off point for the French population-based breast cancer screening program. Cancer Epidemiology, 103, 103136. https://doi.org/10.1016/j.canep.2026.103136

Vancouver

Koïvogui A, Abihsera G, Saifi S, Deghaye M, Lamarque D, Cherel P, et al. Combining artificial intelligence analysis with expert mammogram reading: Determining the optimal AI positivity cut-off point for the French population-based breast cancer screening program. Cancer Epidemiology. 2026;103:103136. doi:10.1016/j.canep.2026.103136

BibTeX
@article{Kovogui2026,
  author = {Koïvogui, Akoï and Abihsera, Gaëlle and Saifi, Samira and Deghaye, Michel and Lamarque, Dominique and Cherel, Pascal and Herpe, Guillaume and Sellier, Nicolas},
  title = {Combining artificial intelligence analysis with expert mammogram reading: Determining the optimal AI positivity cut-off point for the French population-based breast cancer screening program},
  journal = {Cancer Epidemiology},
  year = {2026},
  volume = {103},
  pages = {103136},
  doi = {10.1016/j.canep.2026.103136}
}
Kostenlos starten →